Europe has an impressive history and track record in the biomedical sciences. The knowledge and expertise in the areas of virology, immunology, vaccinology, genomics, epidemiology, and more, are essential assets for the Human Vaccine Project to mobilize and involve stakeholders across the public and private sectors.
The purpose of the Amsterdam-based European Program is to contribute to the overall objective of the Human Immunome Project (formerly known as Human Vaccines Project) to decode the human immune system and to accelerate the development of vaccines, immunotherapies and diagnostics to prevent, treat and cure diseases.
The Stichting’s focus is on outreach, advocacy, fundraising, creating partnerships and consortia to shape and strengthen the European contribution to the global research program by:
- Establishing a network of leading European centers for human immunology and vaccinology networks centers and connecting them to the mission and activities of the Human Immunome Project.
- Advocating for scientific prioritization of the decoding of the immunome.
- Working together with government institutions, academia, industry and non-state actors – building champions and powerful alliances.
- Mobilizing financial support from the public, private and philanthropic sector.